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Response to Surti et al.: ‘Pregnancy and liver transplantation’
To the Editor:
Surti and colleagues note in their comprehensive review of
pregnancy following liver transplantation that the timing of
pregnancyislinkedtoitssuccess:thelongerafter transplantation,
the lower the rate of obstetrical and graft-related complications
(1–3). In order to achieve this goal, women must have access to
reliable and effective contraception. While the AST consensus
statement (4) recommends against the use of intrauterine devices
(IUDs), the evidence cited for this is thin. It is based solely upon
two cases reported in a single article in 1981 (5). Moreover, the
risk of IUD-related pelvic infection in other immune-compro-
mised individuals in not signiﬁcantly increased compared with
women with an intact immune system (6). Given these facts,
when counselling women with a transplant, IUDs should be
routinely offered as a ﬁrst line method of contraception.
Intrauterine devices are used successfully and safely by women
with many different types of transplants in my practice (and those
of otherexperiencedfamily planning providers). Thisletterisa call
to the research community in the ﬁelds of organ transplantation
and family planning to collaborate in an effort to investigate this
important issue in more detail. Following this, appropriate,
evidence-based recommendations could be made to aid clinicians
and patients in selecting the best method of contraception. This
will ensure that women with transplants remain healthy and are
given the best opportunity to experience a healthy pregnancy.
Christopher M. Estes
Department of Obstetrics and Gynecology, Reproductive Health
Services, University of Miami Miller School of Medicine, Miami,
FL, USA
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IUD in transplant recipients
To the Editor:
Intra-uterine devices (IUDs) are an underutilized form of
contraception despite its conﬁrmed safety and efﬁcacy in the
general population (1). We appreciate the letter by Dr Estes
regarding the need for further research in the use of IUDs in
transplant recipients (2, 3). The use of IUDs in the transplant
population is associated with concerns of lack of efﬁcacy and
increased risk of infection despite the paucity of published data.
We are only aware of two published cases reporting IUD
failure in transplant recipients (4). Another case report ad-
dresses the risk of infection, in which a levonorgestrel IUD was
used to treat uterine myomas in a patient 4 years post-renal
transplant (5). Although the report did not discuss IUD use as
contraception, the patient was asymptomatic and did not
develop any infection up to 1 year after device insertion (5).
Recent studies have demonstrated safe and efﬁcacious use of
IUDs in other immunocompromised patients such as those
with HIV (6, 7) and lupus (8). Whether these data can be
extrapolated to transplanted patients is debatable.
Although we agree that IUDs would likely provide a safe and
effective method of contraception in transplant patients, there
are little or no data supporting this and therefore no guidelines
or endorsements from the major transplant societies. We hope
these discussions promote awareness and encourage investiga-
tion and reporting of IUDs in the transplant population.
Bujil Surti and Sammy Saab
David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
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